Inflammation plays a central role in the pathogenesis and clinical manifestations of atherosclerosis. Randomized controlled trials have investigated the potential benefit of colchicine in reducing cardiovascular (CV) events in patients with coronary artery disease (CAD) but produced conflicting results. The aim of this meta-analysis was to evaluate the efficacy and safety of colchicine in patients with CAD.
We partnered with the 200th Samobor Carnival (Samoborski fašnik) — one of the largest and most traditional public events in Croatia — transforming a major
It was a great pleasure to announce that our colleague Lokman H. Tanriverdi, MD, PhD received the 2026 Prof. Dr. R. Kazım Türker Young Pharmacologist Incentive
On 29th of January we hosted an outstanding meeting held under the auspices of the International Lipid Expert Panel (ILEP), the European Program for Prevention (EPP,
Lublin and KUL Warm Welcome Welcome message and main information on the Summit EU Safe Hearts Plan – prevention as the main strategy in the